ARYA Sciences Acquisition Corp III
Status: Deal Closed
U=S
| IPO Proceeds, $M | $149.50M |
|---|---|
| IPO Date | Aug 7, 2020 |
| CEO | Adam Stone |
| Left Lead | Jefferies |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector |
Healthcare
Life sciences and medical technologies in North America and Europe |
| IPO Geography | Global |
| Target Company | Nautilus Biotechnology |
| Deal Announced | Feb 8, 2021 |
| Deal Size, $M | $905.37M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings | www.sec.gov |
| Approval Vote | Jun 8, 2021 |
| Amendment Vote | TBD |
| Closing Date | Jun 9, 2021 |
Formerly ARYA
NAUT
| Price | $2.34 |
|---|---|
| Last closing price | $2.24 |
| H/L, today | $2.21 / $2.35 |
| H/L, 52-week | $1.50 / $4.65 |
| Volume, today | 68,323 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on ARYA Sciences Acquisition Corp III:
- Structure and cap table
- 7 directors & officers
- 17 filings and events
- 2 underwriters
- 5 deal advisors
- 3 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Joseph Edelman | 64 | Chairman |
| Adam Stone | 40 | CEO and Director |
| Michael Altman | 38 | CFO and Director |
| Konstantin Poukalov | 36 | Chief Business Officer |
| Todd Wider | 55 | Director |
| Bradley L. Campbell | 45 | Director |
| Saqib Islam | 51 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Jefferies | Joint BR | 6,500,000 | units |
| Goldman Sachs | Joint BR | 6,500,000 | |
| 13,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.